Skip to content

Analysis of the Efficacy of Stellate Ganglion Embedding Therapy Combined with Check Acupuncture in the Treatment of Chronic Insomnia: A Randomized Controlled Trial

Analysis of the Efficacy of Stellate Ganglion Embedding Therapy Combined with Check Acupuncture in the Treatment of Chronic Insomnia: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600117286
Enrollment
Unknown
Registered
2026-01-22
Start date
2026-02-01
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia

Interventions

Stellate Ganglion Catgut Embedding Group (Group M):Patients in Group M received stellate ganglion catgut embedding treatment. Treatment Cycle: One session of catgut embedding was administered at the f
Buccal Acupuncture Group (Group J):Patients in Group J received buccal acupuncture treatment. Treatment Cycle: Three sessions per week (e.g., Monday, Wednesday, and Friday) for two consecutive weeks,
Buccal Acupuncture Combined with Stellate Ganglion Catgut Embedding Group (Group JM):The intervention regimen was the simultaneous combination of the protocols used in Group J and Group M.

Sponsors

Ningxia Hui Autonomous Region People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18 to 65 years. 2.Meeting the diagnostic criteria for chronic insomnia as specified in the International Classification of Sleep Disorders, 3rd Edition (ICSD-3) and Diagnostic and Treatment Guidelines for Insomnia (2025 Edition). 3.Baseline heart rate >= 60 beats per minute. 4.No use of sedative-hypnotic drugs (e.g., benzodiazepines, Z-drugs), antidepressants, or central nervous system stimulants that may affect sleep within 2 weeks prior to enrollment. 5.Voluntary participation in the study and provision of written informed consent.

Exclusion criteria

Exclusion criteria: 1.Having severe irregular daily routines (e.g., frequent night shifts). 2.Being pregnant or lactating women. 3.Having a history of drug or alcohol dependence. 4.Receiving anticoagulant/antiplatelet therapy (e.g., warfarin, aspirin). 5.Being allergic to catgut embedding materials (polyglycolic acid-lactic acid copolymer, PGLA). 6.Complicated with severe uncontrolled heart, lung, brain, or kidney diseases, or malignant tumors. 7.Having severe mental or cognitive disorders (e.g., major depression, schizophrenia) that prevent cooperation with the study. 8.Having infections, anatomical abnormalities, or severe cervical spine diseases on the face or neck.

Design outcomes

Primary

MeasureTime frame
Improvement rate of PSQI score;

Countries

China

Contacts

Public ContactWu Xiping

Ningxia Hui Autonomous Region People's Hospital

wxp203@163.com+86 159 0960 4547

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026